diplomatic roadshow

The Brazilian government recently reached an agreement with the producers of the HIV/AIDS drug Kaletra to reduce its price by 29.5 per cent. Following the deal, Thailand has also demanded higher

Brazil recently issued a compulsory licence that will allow the manufacture of generic versions of a drug, which is used to treat hiv/aids patients. The drug, Sustiva (efavirenz), is marketed as

cell phone Ban

Norway has urged the Swiss pharma major Novartis to withdraw its patents case against India (see

The multinational pharmaceutical corporation Abbott Laboratories announced a significant cut in the cost of its life-saving drug Kaletra (a protease inhibitor to treat hiv/aids) in 40 developing

Anaemia is a widespread condition in India. The biggest cause is malnourishment and iron-poor diets. Though the best remedy is a good diet, anaemia has spawned a huge market for iron supplements,